1.
Taskaynatan H, Kucukzeybek Y, Yildiz Y, Salman T, Oflazoglu U, Varol U, Alacacioglu A, Saray S, Ozdemir O, Oktay Tarhan M. Low dose (d1-5/7) oral etoposide regimen in intensively treated platinum-resistant epithelial ovarian cancer: The ─░zmir oncology group (IZOG) study . annalsmedres [Internet]. 2021 May 25 [cited 2022 May 16];27(1):0029-33. Available from: https://annalsmedres.org/index.php/aomr/article/view/591